Reviva Pharmaceuticals Holdings Inc — 貸借対照表 (NASDAQ:RVPH) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 8.76 M31.4 M18.92 M23.7 M15.5 M15.92 M 負債合計 1.33 M2.72 M6.61 M17.98 M14.69 M7.28 M 純資産合計 7.43 M28.69 M12.32 M5.72 M812.57 K8.65 M 負債および純資産合計 8.76 M31.4 M18.92 M23.7 M15.5 M15.92 M 有利子負債合計 0————— 純負債 -8.76 M—————

ニュース

Does Cobenfy Have the Potential to Become a Top Drug for BMY?

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.44%

D. Boral CapitalがReviva Pharmaceuticals株の格付けをホールドに引き下げ

D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold

Reviva Pharmaceuticalsが3月9日に1対20の株式併合を実施

Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9

Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia

Chardan Capital、Reviva Pharmaceuticals株に「買い」評価で調査開始

Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com

レビバ・ファーマシューティカルズの株式評価、H.C.ウェインライトがBuy評価を維持

Reviva Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright